New Procedure Treats First Patient in a Clinical Trial - Renal Business Today PDF Print
Renal Business Today
Vessix Vascular, Inc., a developer of novel percutaneous radiofrequency (RF) balloon catheter technology, announced today initial patient treatments in the international multi-center REDUCE-HTN renal denervation clinical study for uncontrolled

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.